Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Leiomyoma 1Inflammation 1Frailty 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 454Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × epigallocatechin gallate × Clear all
NCT04553666 2026-05-07

ReFOCUS1

University of Rochester

Phase 2 Completed
24 enrolled 17 charts

Frailty, Inflammation

NCT04177693 2023-06-05

Pharmacokinetics and Hepatic Safety of EGCG

Yale University

Phase 1 Completed
39 enrolled 18 charts

Leiomyoma

NCT00676780 2012-08-08

Green Tea Extract and Prostate Cancer

Louisiana State University Health Sciences Center Shreveport

Phase 2 Completed
33 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡